In one such study, 6 out of 7 hypermutated tumours had mutations in one of the MMR genes MLH1, MSH2, MSH6 and PMS2 compared to only one tumour in 84 non-hypermutated tumours [27]. Here, MLH1 is linked to neoplasm.